COMMUNIQUÉS West-GlobeNewswire

CFN Media Adds Drone Capabilities to Onsite Film Production
18/10/2018
Seattle, WA, Oct. 18, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”, “CannabisFN”), the leading agency and financial media network dedicated to the worldwide cannabis industry, today [...]
Kiadis Pharma launches a private placement of approximately 3.7 million new shares
18/10/2018
Not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, south africa or Any other jurisdiction in which such release, publication or distribution [...]
Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the North American Cystic Fibrosis Conference (NACFC)
18/10/2018
ELX-02 shows significant increases in CFTR function in Cystic Fibrosis patient-derived organoids bearing nonsense mutations in the CFTR gene ELX-02 demonstrated significant increases in CFTR mRNA, with elevations above [...]
The Meritorious Service Medal Awarded to Doctor Éric Nadeau and Doctor John Morris Fairbrother
18/10/2018
MONTREAL, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Prevtec Microbia Inc. (Prevtec) - Dr. Éric Nadeau, co-founder and Vice-President, Scientific Affairs at Prevtec Microbia and adjunct professor at the Faculté de médecine [...]
La Médaille du Service Méritoire décernée aux docteurs Éric Nadeau et John Morris Fairbrother
18/10/2018
MONTRÉAL, 18 oct. 2018 (GLOBE NEWSWIRE) -- Prevtec Microbia inc. (« Prevtec ») - Le docteur Éric Nadeau, cofondateur et Vice-Président aux affaires scientifiques de Prevtec Microbia et professeur associé à la Faculté de [...]
NeuroMetrix Reports DPNCheck to be Featured at Upcoming 33rd Japan Society of Diabetic Complications Annual Meeting in Tokyo
18/10/2018
WALTHAM, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), reported that DPNCheck ® , its rapid, point-of-care test for diabetic peripheral neuropathy (DPN), will be featured in several [...]
OV - First prostate cancer patient included in Oncology Venture's Phase 2 study of Irofulven for personalized treatment
18/10/2018
Hoersholm, Denmark, October 18, 2018 - Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) announces the inclusion of the first patient in a Phase 2 study of Irofulven - a drug candidate that exploits cancer [...]
Whistler Medical Marijuana Secures Cultivation Licence for Flagship Pemberton Facility
18/10/2018
WHISTLER, British Columbia, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Whistler Medical Marijuana Corp. (“WMMC” or the “Company”), Canada’s original organic certified producer of medical cannabis, is pleased to announce they [...]
IntelGenx Announces Pricing of $12 Million Equity Offering
18/10/2018
SAINT LAURENT, Quebec, Oct. 18, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “ Company ” or “ IntelGenx ”) announced today the pricing of an agency offering (the “ Offering ”) of [...]
iAnthus and MPX Bioceutical Announce Transformational Combination, Expands U.S. Footprint to 10 States
18/10/2018
NEW YORK and TORONTO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”), (CSE: IAN, OTCQX: ITHUF), and MPX Bioceutical Corporation (“MPX”) (CSE: MPX; OTC:MPXEF) announced [...]
BioRestorative Therapies Announces the Appointment of Lance Alstodt as Executive VP and Chief Strategy Officer
18/10/2018
MELVILLE, N.Y., Oct. 18, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today announced the [...]
Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin® Test in China
18/10/2018
RUTHERFORD, N.J., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today [...]
Making Breast Cancer Surgery Easier for Women: Over 50,000 Women in U.S. Experienced Wire-free Breast Tumor Localization with SAVI SCOUT®
18/10/2018
ALISO VIEJO, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Cianna Medical, Inc., the world leader in wire-free breast localization, announced that over 375 hospitals across the United States have collectively performed over [...]
RefleXion to Unveil New Approach to Cancer Treatment at ASTRO
18/10/2018
Biology-guided Radiotherapy May Improve Physician Confidence in Treatment of Multiple Tumors HAYWARD, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- RefleXion Medical , a biotargeting oncology company using each cancer’s [...]
CTV Toronto Highlights FSD Pharma’s Cobourg Facility -- CFN Media
18/10/2018
SEATTLE, Oct. 18, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Predictive Technology Group Appoints Charles Andres to Its Scientific Advisory Board
18/10/2018
SALT LAKE CITY, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC/PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through [...]
Ultragenyx Announces Approval of Mepsevii™ (vestronidase alfa) in Brazil for the Treatment of Mucopolysaccharidosis VII
18/10/2018
Mepsevii, an enzyme replacement therapy, is the first treatment approved in Latin America for this rare genetic disease NOVATO, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a [...]
Intellia Therapeutics Presents New Data in In Vivo and Ex Vivo Programs at the 26th Annual Congress of the European Society of Gene and Cell Therapy
18/10/2018
Intellia scientists present first robust demonstration of CRISPR-mediated insertion of transgenes in the liver Non-human primate data show high correlation achieved between liver edit and reduction of TTR protein High [...]
OpGen Announces Pricing of Public Offering of Common Stock
18/10/2018
GAITHERSBURG, Md., Oct. 18, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) today announced the pricing of an underwritten public offering of approximately 2.2 million shares of its common stock at a public offering [...]

Pages